Coronavirus SARS-CoV2: BESSY II data accelerate drug development

Schematic representation of the coronavirus protease. The enzyme comes as a dimer consisting of two identical molecules. A part of the dimer is shown in colour (green and purple), the other in grey. The small molecule in yellow binds to the active centre of the protease and could be used as blueprint for an inhibitor.

Schematic representation of the coronavirus protease. The enzyme comes as a dimer consisting of two identical molecules. A part of the dimer is shown in colour (green and purple), the other in grey. The small molecule in yellow binds to the active centre of the protease and could be used as blueprint for an inhibitor. © H. Tabermann/HZB

Filmclip: At BESSY II, the main protease of SARS-CoV2 has been decoded. This might help to develop drugs. © HG Medien/HZB

01:11

A coronavirus is keeping the world in suspense. SARS-CoV-2 is highly infectious and can cause severe pneumonia with respiratory distress (COVID-19). Scientists are doing research in order to prevent the viruses from multiplying. A team from the University of Lübeck and from Helmholtz Centre for Infection Research (HZI) has now found a promising approach. Using the high-intensity X-ray light from the Berlin synchrotron source BESSY II, they have decoded the three-dimensional architecture of the main protease of SARS-CoV-2. This protein is involved in the reproduction of the virus. Analysing its 3D architecture allows the systematic development of drugs which inhibit the reproduction of the virus.

Teams around the world are working hard to develop active substances against SARS-CoV-2. The structural analysis of functional proteins of the virus is very helpful for this goal. The function of a protein is closely related to its 3D architecture. If this 3D architecture is known, it is possible to identify specific points of attack for active substances.

Inhibiting the reproduction

A special protein is involved in the reproduction of the virus: the viral main protease (Mpro or also 3CLpro). A team led by Prof. Dr. Rolf Hilgenfeld, University of Lübeck, has now decoded the 3D architecture of the main protease of SARS-CoV-2. The researchers have used the high-intensity X-ray light from the BESSY II facility of the Helmholtz-Zentrum Berlin.

Fast track at BESSY II

"For such issues of highest relevance, we can offer fast track access to our instruments", says Dr. Manfred Weiss, who heads the Research Group Macromolecular Crystallography (MX) at HZB. At the so-called MX instruments tiny protein crystals can be analysed with highly brilliant X-ray light. The images contain information about the 3D architecture of the protein molecules. The complex shape of the protein molecule and its electron density is then calculated by computer algorithms.

Targets for active substances

The 3D architecture provides concrete starting points for developing active substances or inhibitors. These drugs could dock specifically to target points of the macromolecule and impede its function. Rolf Hilgenfeld is a world-renowned expert in the field of virology and already developed an inhibitor against the SARS-virus during the 2002/2003 SARS pandemic. In 2016, he succeeded in deciphering an enzyme of the Zika virus. 

 

Science, 20. March 2020: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld

DOI: 10.1126/science.abb3405 

arö

You might also be interested in

  • HZB physicist appointed to Gangneung-Wonju National University, South Korea
    News
    25.01.2023
    HZB physicist appointed to Gangneung-Wonju National University, South Korea
    Since 2016, accelerator physicist Ji-Gwang Hwang has been working at HZB in the department of storage rings and beam physics. He has made important contributions to beam diagnostics in several projects at HZB. He is now returning to his home country, South Korea, having accepted a professorship in physics at Gangneung-Wonju National University.
  • Scientists Develop New Technique to Image Fluctuations in Materials
    Science Highlight
    18.01.2023
    Scientists Develop New Technique to Image Fluctuations in Materials
    A team of scientists, led by researchers from the Max Born Institute in Berlin and Helmholtz-Zentrum Berlin in Germany and from Brookhaven National Laboratory and the Massachusetts Institute of Technology in the United States has developed a revolutionary new method for capturing high-resolution images of fluctuations in materials at the nanoscale using powerful X-ray sources. The technique, which they call Coherent Correlation Imaging (CCI), allows for the creation of sharp, detailed movies without damaging the sample by excessive radiation. By using an algorithm to detect patterns in underexposed images, CCI opens paths to previously inaccessible information. The team demonstrated CCI on samples made of thin magnetic layers, and their results have been published in Nature.
  • Recommended reading: Bunsen magazine with focus on molecular water research
    News
    13.01.2023
    Recommended reading: Bunsen magazine with focus on molecular water research
    Water not only has some well-known anomalies, but is still full of surprises. The first issue 2023 of the Bunsen Magazine is dedicated to molecular water research, from the ocean to processes in electrolysis. The issue presents contributions from researchers cooperating within the framework of a European research initiative in the "Centre for Molecular Water Science" (CMWS). A team at HZB presents results from the synchrotron spectroscopy of water. Modern X-ray sources can be used to study molecular and electronic processes in water in detail.